BMY vs NBIX
Bristol Myers Squibb vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | BMY | NBIX |
|---|---|---|
| AI Score | 65 | 66 |
| Price | $62.09 | $175.67 |
| P/E Ratio | 17.44× | 26.20× |
| ROE | 0.4% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 1.0% |
| Debt / Equity | 2.22× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 70.5 | 56.8 |
| Beta | 0.235 | 0.386 |
| Expected Upside | +1.3% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
NBIX Full Analysis